Complera and Pancreatogenous diabetes - from FDA reports


There is no Pancreatogenous diabetes reported by people who take Complera yet. This review analyzes which people have Pancreatogenous diabetes with Complera. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Complera and have Pancreatogenous diabetes, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Complera and have Pancreatogenous diabetes

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jun, 29, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Pancreatogenous diabetes when taking Complera?


Complera has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate. It is often used in hiv infection. (latest outcomes from Complera 376 users)

Pancreatogenous Diabetes

Pancreatogenous diabetes has been reported by people with bipolar disorder, depression, insomnia, deep venous thrombosis, pain (latest reports from 38 Pancreatogenous diabetes patients).

Browse all side effects of Complera

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Pancreatogenous diabetes

Pancreatogenous diabetes

Could your condition cause Pancreatogenous diabetes

Pancreatogenous diabetes

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Complera and have Pancreatogenous diabetes.

You may be interested in these reviews

More reviews for: Complera, Pancreatogenous diabetes